Clinical trial
Ziprasidone and Sertraline in PTSD
NCT00248261 · Universitätsklinikum Hamburg-Eppendorf, Other · Terminated
Key facts
| NCT number | NCT00248261 |
|---|---|
| Title | Ziprasidone and Sertraline in PTSD |
| Official title | Effects of Ziprasidone vs. Placebo During the First Four Weeks of Eight Weeks Sertraline Treatment in Patients With Post-traumatic Stress Disorder (PTSD) |
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Post-traumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | ziprasidone, sertraline |
| Enrollment | 7 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Nov 3, 2005 |
| Last update posted | Feb 25, 2020 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: